BRAIN Biotech AG at a Glance

We are an enzyme discovery, development and manufacturing company and a key player in the bioeconomy

Headquarter	Zwingenberg, Germany (Hesse)
Year of Foundation	1993
Employees	281 (as of September 2025)
Revenues	49.6 Mio Euro (Financial Year 2024/25)
Specialists knowledge	Biology, microbiology, biochemistry, chemistry, bioinformatics, artificial intelligence, bioprocess engineering, food technology, analytics, etc.
Markets	Food & Beverages, Pharma, Life Science, Environment
Patents	35 active patent families with varying numbers of individual patents
Services, solutions, products	Manufacturing: Large-scale production and refinement of enzymes and further proteins. Enzyme technology: Discover, analyze, optimize and produce enzymes on an industrial scale in a variety of microbial production organisms. Production strain development: microorganism identification; microbial strain development (non-GMO and GMO); provision of functional biomass to optimize industrial production processes. Bioprocess development: Developing production processes on a laboratory scale; process validation and sample generation; process transfer to industrial production scale.
Business segments (since 3M 2024/25)	BRAINBiocatalysts Development, production and distribution of specialty enzymes, microorganisms, ingredients BRAINBioIncubator Research-intensive development projects, pharmaceuticals

BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The group´s headquarter is located in Zwingenberg, South Hesse, Germany.

BRAIN Biotech AG has been listed in the Prime Standard segment of the Frankfurt Stock Exchange since February 9, 2016 (ticker symbol: BNN; securities identification number: ISIN DE0005203947/WKN 520394).

Subsidiaries

BRAIN Biotech AG had the following operating units as of the end of the reporting year (30 September 2025): BRAIN UK II Ltd., Cardiff, UK; Biocatalysts Ltd., Cardiff, UK; Biocatalysts Inc.*, Tampa, Florida, USA; WeissBioTech GmbH, Ascheberg, Germany; Breatec B.V.**, Nieuwkuijk, Netherlands; RMH AG (formerly Akribion Genomics AG), Zwingenberg, Germany; AnalytiCon Discovery LLC, Rockville, Maryland, USA.